Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling

NCT06313398 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

100

Enrollment

NIH

Sponsor class

Conditions

Sickle Cell Disease
Thalassemia
Hemoglobinopathy

Interventions

BIOLOGICAL: Biotin-labeled red blood cells

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)

Collaborators

[object Object]